ARTEMISMED

Artemis Medicare Services Ltd.

NSE: ARTEMISMED

BSE: 542919

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Hospital

269.35-6.0 (-2.20%)

17 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

84.6 / 100

Value Score

30.3 / 100

Price Momentum Score

76.1 / 100

QVM Score

76.9 / 100

Key Metrics

Market Cap

4263.97

P/E (TTM)

41.15

P/B

4.56

P/S (TTM)

3.94

EV/EBITDA

22.87

CAPE (5Y)

65.79

ROE (TTM)

11.69

ROCE (TTM)

12.00

ROA (TTM)

7.44

Avg 3Y ROE

12.03

Earnings 3Y CAGR

33.05

Sales 3Y CAGR

13.61

Sales 5Y CAGR

21.50

Debt/Equity

0.28

Consensus TP

328.00

Strong Buy %

33.33

Promoter Holding

58.39

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Artemis Medicare Services Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 76.1 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

76.1 / 100

Moderate operating margin but improving trend

The company reported moderate operating margin of 12.96% for 12-month ended 31 Mar 2026 but operating margin improved by 155 bps from 1 year ago

What is Operating profit margin?

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 23.62% for 12-month ended 31 Mar 2026 and the growth was 6.63 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.28 as on 31 Mar 2026 and Debt to Equity decreased marginally by 0.07 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 3 financial years

What is Dividend streak?

Negative

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -10.54% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Not enough data

Moderate revenue growth but lower than median growth of industry

The company delivered moderate revenue growth of 15.4% for 12-month ended 31 Mar 2026 but the growth was 3.41 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 18.81

Value 15.4

-17.1910376.7

Low dividend yield

The company has a low dividend yield of 0.17%

What is Dividend yield?

Neutral

Stock appears expensive but is at a discount to industry median P/E

PE TTM of 41.15 indicates that the stock is expensive on a standalone basis but discount to industry median P/E is decent at -16.8%

What is P/E Ratio?

Median: 49.46

Value 41.15

-43.743178.89

Moderate and stable ROE

The company reported moderate ROE of 11.69% for 12-month ended 31 Mar 2026 and ROE declined marginally by -115 bps from 1 year ago

What is ROE (FY)?

Company's earnings are of moderate quality

Earnings quality score of 64.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

64.0 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Artemis Medicare Services Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Artemis Medicare Services Ltd. Shareholding Pattern

Quarterly breakdown of Artemis Medicare Services Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	69.82	69.82	69.82	69.82	69.82	69.82	69.82	69.82	69.82	69.59	69.27	68.92	68.92	68.03	68.03	68.03	68.03	67.51	67.17	67.17	67.17	66.53	66.53	58.39	58.39	58.39
Indian Promoter	69.82	69.82	69.82	69.82	69.82	69.82	69.82	69.82	69.82	69.59	69.27	68.92	68.92	68.03	68.03	68.03	68.03	67.51	67.17	67.17	67.17	66.53	66.53	58.39	58.39	58.39
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	8.59	8.59	8.59	8.59	8.59	8.59	8.59	8.59	8.47	8.25	8.21	8.42	8.65	8.66	8.79	9.25	9.89	10.73	10.91	12.23	12.44	12.02	11.66	21.54	21.24	20.85
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	0.07	0.32	0.79	1.23	1.22	1.74	1.96	1.96	2.01	1.69	1.69	1.30
FI/Bank/Insurance	0.91	0.91	0.91	0.91	0.91	0.91	0.91	0.91	0.91	0.91	0.90	0.89	0.89	0.88	0.88	0.88	0.88	0.88	1.16	1.36	1.58	1.55	1.32	0.76	0.76	0.76
Govt	7.37	7.37	7.37	7.37	7.37	7.37	7.37	7.37	7.37	7.34	5.06	7.27	7.27	7.18	7.18	7.18	7.18	7.12	7.09	7.09	7.09	7.02	7.02	6.16	6.16	6.16
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.09	0.11	0.10	0.16	0.21	0.65	0.31	0.24	0.37	12.47	12.19	12.29
Other Institutions	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.19	0.00	2.25	0.26	0.48	0.53	0.56	0.77	0.94	1.34	1.22	1.40	1.50	1.25	0.94	0.46	0.44	0.34
Non-Institution	21.59	21.59	21.59	21.59	21.59	21.59	21.59	21.59	21.71	22.17	22.52	22.66	22.44	23.31	23.18	22.72	22.08	21.76	21.92	20.60	20.39	21.46	21.81	20.08	20.37	20.76
Bodies Corporate	9.24	9.04	8.94	8.51	8.04	4.61	4.48	2.78	2.71	3.89	2.30	2.13	2.14	2.63	2.52	2.52	2.43	2.25	2.17	2.10	1.98	2.09	2.10	2.29	2.27	2.18
Others (incl. Retail) No. of shareholders	12.35 5,487	12.55 5,536	12.65 5,542	13.08 5,329	13.55 5,184	16.98 5,920	17.11 10,663	18.81 12,724	19.00 11,999	18.28 15,065	20.22 14,525	20.53 17,883	20.30 17,980	20.68 18,945	20.66 20,374	20.20 22,218	19.65 19,834	19.51 19,621	19.75 25,851	18.50 26,784	18.41 28,206	19.37 31,419	19.71 33,339	17.79 31,389	18.10 31,834	18.58 36,108

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Hospital	1.66%	14 / 18

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Artemis Medicare Services Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Average price	Qty.	Transaction value
Neeru Wahal Immediate Relative	June-2021	Market Purchase (Acquisition) 22nd Jun 2021	₹ 301.52	1.64 k	₹ 4.95 lac
Neeru Wahal Immediate Relative	June-2021	Market Purchase (Acquisition) 22nd Jun 2021	₹ 300.81	1.36 k	₹ 4.09 lac
Prem Narain Wahal Designated Person	June-2021	Market Purchase (Acquisition) 22nd Jun 2021	₹ 301.72	605.00	₹ 1.83 lac
Prem Narain Wahal Designated Person	June-2021	Market Purchase (Acquisition) 22nd Jun 2021	₹ 300.70	2.52 k	₹ 7.57 lac

Corporate Actions

History of Artemis Medicare Services Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.45/share
Record date: 10th Jul 2026Ex-date: 10th Jul 2026
Announced on: 8th May 2026
Dividend₹ 0.45/share
Record date: 11th Jul 2025Ex-date: 11th Jul 2025
Announced on: 12th May 2025
Dividend₹ 0.45/share
Record date: 5th Jul 2024Ex-date: 5th Jul 2024
Announced on: 10th May 2024
Dividend₹ 0.45/share
Record date: 14th Jul 2023Ex-date: 14th Jul 2023
Announced on: 5th May 2023
Stock Split1 : 10
Ex-date: 23rd Sep 2021Announced on: 5th Aug 2021
Nominal value changes from INR 10 to INR 1

Company Profile

Overview of Artemis Medicare Services Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Artemis Medicare Services Limited is an India-based company. The Company manages and operates a multi-specialty hospital. It specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient services. It offers treatment facilities for various medical condition...

Key personnel

Mr. Sanjiv Kumar Kothari

Chief Financial Officer

Ms. Poonam Makkar

Compliance Officer, Company Secretary

Mr. Onkar S. KanwarD

Non-Executive Chairman of the Board

Dr. Devlina ChakravartyD

Managing Director, Executive Director

Ms. Shalini Kanwar ChandD

Non-Executive Non-Independent Director

Mr. Neeraj Singh KanwarD

Non-Executive Non-Independent Director

Mr. Sunam SarkarD

Additional Non-Executive Non-Independent Director

Mr. Akshaykumar Narendrasinhji ChudasamaD

Non-Executive Independent Director

View all

Incorporated on

18 May 2004

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

2,055

IPO date

23 Jan 2020

Free Float

3,01,32,620

Website

https://www.artemishospitals.com/

Phone no.

+911244511111

Address

ARTEMIS HOSPITAL SECTOR 51, , 122001, India

Frequently Asked Questions

What is the current share price of Artemis Medicare Services Ltd.?

The current share price of Artemis Medicare Services Ltd. is ₹ 269.35 as of 17 Jul 2026.

What is the market capitalisation of Artemis Medicare Services Ltd.?

The market capitalisation of Artemis Medicare Services Ltd. stands at ₹ 4,263.97 Cr.

What is the PE ratio of Artemis Medicare Services Ltd.?

The Price-to-Earnings (PE) ratio of Artemis Medicare Services Ltd. is 41.15 as of the latest trailing twelve months data.

What is the ROE and ROCE of Artemis Medicare Services Ltd.?

Artemis Medicare Services Ltd. has a Return on Equity (ROE) of 11.69% and a Return on Capital Employed (ROCE) of 12.00% as per the latest financial reports.

What is the 52-week high and low of Artemis Medicare Services Ltd.?

The 52-week high of Artemis Medicare Services Ltd. is - and the 52-week low is -.

What is the dividend yield of Artemis Medicare Services Ltd.?

The dividend yield of Artemis Medicare Services Ltd. is 0.17% based on the current market price.

What is the FII and DII holding in Artemis Medicare Services Ltd.?

Foreign Institutional Investors (FII) hold 12.29%, Domestic Institutional Investors (DII) hold 2.06% and retail/public investors hold 18.58% of Artemis Medicare Services Ltd. shares.

What sector does Artemis Medicare Services Ltd. belong to?

Artemis Medicare Services Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Artemis Medicare Services Ltd. with a consensus target price of ₹ 328.00, implying 21.77% upside from current levels.

What is the beta of Artemis Medicare Services Ltd.?

The beta of Artemis Medicare Services Ltd. is 0.75, indicating its price volatility relative to the broader market. Over the past 1 year, Artemis Medicare Services Ltd. has delivered an absolute return of 6.88%.

What is the RSI of Artemis Medicare Services Ltd.?

The 14-day Relative Strength Index (RSI) of Artemis Medicare Services Ltd. is 51.09, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Artemis Medicare Services Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Artemis Medicare Services Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Holdings and Presence

Corporate Actions